G Cenderello
Overview
Explore the profile of G Cenderello including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Taramasso L, Liggieri F, Cenderello G, Bovis F, Giannini B, Mesini A, et al.
Sci Rep
. 2019 Apr;
9(1):5418.
PMID: 30931978
Retrospective multicentre study aiming at analysing the etiology, characteristics and outcome of bloodstream infections (BSI) in people living with HIV (PLWHIV) in an era of modern antiretroviral therapy. Between 2008...
2.
Foca E, Cavaglia G, Rusconi S, Cascavilla A, Cenderello G, Re A, et al.
HIV Med
. 2018 Jun;
PMID: 29862615
Objectives: Lymphoproliferative disorders are often observed in HIV-positive patients. Combination antiretroviral treatment (cART) during antineoplastic chemotherapy is beneficial, but little is known about the clinical outcome according to different antiretroviral...
3.
Goossens N, De Vito C, Mangia A, Clement S, Cenderello G, Barrera F, et al.
J Viral Hepat
. 2018 Mar;
25(8):920-929.
PMID: 29532619
It remains unclear whether hepatitis B virus (HBV) infection may modify the severity of viral steatosis in patients coinfected with chronic hepatitis C virus (HCV). We examined the influence of...
4.
Mangia A, Sarli R, Gamberini R, Piga A, Cenderello G, Piazzolla V, et al.
Aliment Pharmacol Ther
. 2017 Jun;
46(4):424-431.
PMID: 28660640
Background: Patients with thalassaemia major depend on blood transfusions. In Italy, up to 80% of thalassaemia patients bear HCV antibodies due to HCV contaminated transfusions before 1990. Thalassaemia patients with...
5.
Venturini A, Cenderello G, Di Biagio A, Giannini B, Ameri M, Giacomini M, et al.
AIDS Care
. 2017 Feb;
29(11):1373-1377.
PMID: 28150510
The aims of this study were to assess the Health Related Quality of Life (HRQoL) of People Living with HIV/AIDS (PLWHA) who attend outpatient services in Genoa, Italy, and to...
6.
Dentone C, Sterrantino G, Signori A, Cenderello G, Guerra M, De Leo P, et al.
Int J STD AIDS
. 2017 Feb;
28(11):1067-1073.
PMID: 28142395
The aim of this retrospective, multicentre, observational study was to assess the durability, safety, immune recovery and effectiveness on viral suppression of antiretroviral therapy (ART) in a maraviroc (MVC)-based cohort....
7.
Riccardi N, Cenderello G, Costa M, Cassola G
Infection
. 2017 Jan;
45(3):391-392.
PMID: 28063127
No abstract available.
8.
Calcagno A, Montrucchio C, Capetti A, Guaraldi G, Cenderello G, Calza L, et al.
Curr HIV Res
. 2015 Sep;
14(1):54-60.
PMID: 26415700
Background: Tolerability, long-term toxicities and selection of resistant variants limit the use and efficacy of antiretroviral drugs in HIV-positive patients. Novel combinations are needed for mantaining long-term control of HIV...
9.
Cenderello G, Pontali E, Cassola G, Torresin A
Infection
. 2012 Oct;
41(1):199-202.
PMID: 23065464
Highly active antiretroviral therapy (HAART) has proven long-term efficacy in human immunodeficiency virus (HIV) infection. Combination therapy with pegylated interferon and ribavirin has become the standard of care in patients...
10.
Costa P, Bozzano F, Fenoglio D, Beltrame A, Cenderello G, Di Biagio A, et al.
Clin Exp Immunol
. 2009 Sep;
158(1):55-63.
PMID: 19737231
Anti-retroviral treatment (ART) usually results in efficient control of virus replication and in immune reconstitution. Among potential adverse effects, impairment of immune responses in terms of CD4(+) T cell counts...